Karen K. Mcginnis net worth and biography

Karen Mcginnis Biography and Net Worth

CAO of Illumina
Mrs. Karen K. McGinnis has been Vice President and Chief Accounting Officer of Illumina, Inc. since November 14, 2017. Mrs. McGinnis served as the Chief Executive Officer and President of Mad Catz Interactive Inc. from February 5, 2016 to March 30, 2017. Mrs. McGinnis served as the Chief Financial Officer of Mad Catz Interactive Inc. since June 10, 2013 and served as its Principal Accounting Officer. She served as the Chief Accounting Officer, Corporate Controller and Vice President of Cymer, Inc. from November 30, 2009 to May 30, 2013. She served as the Chief Accounting Officer of Insight Enterprises Inc. from September 2006 to March 31, 2009 and its Assistant Secretary from January 2005 to March 31, 2009. She served as Senior Vice President of Finance of Insight Enterprises Inc. since April 2001 and also served as its Senior Vice President. Mrs. McGinnis joined Insight Enterprises, Inc. in March 2000 as its Vice President of Finance. From 1997 to 2000, she served as the Chief Financial Officer of Horizon. From 1989 to 1997, Mrs. McGinnis was employed by KPMG LLP and served as its Senior Assurance Manager. She served as a Director of Mad Catz Interactive Inc. from February 5, 2016 to March 30, 2017. Mrs. McGinnis is a Certified Public Accountant and received her Bachelor of Science degree in Accounting from the University of Oklahoma.

What is Karen K. Mcginnis' net worth?

The estimated net worth of Karen K. Mcginnis is at least $2.86 million as of July 26th, 2021. Ms. Mcginnis owns 15,000 shares of Illumina stock worth more than $2,861,850 as of September 30th. This net worth estimate does not reflect any other assets that Ms. Mcginnis may own. Learn More about Karen K. Mcginnis' net worth.

How do I contact Karen K. Mcginnis?

The corporate mailing address for Ms. Mcginnis and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Karen K. Mcginnis' contact information.

Has Karen K. Mcginnis been buying or selling shares of Illumina?

Karen K. Mcginnis has not been actively trading shares of Illumina during the last ninety days. Most recently, Karen K. Mcginnis sold 218 shares of the business's stock in a transaction on Wednesday, November 18th. The shares were sold at an average price of $300.00, for a transaction totalling $65,400.00. Following the completion of the sale, the chief accounting officer now directly owns 1,538 shares of the company's stock, valued at $461,400. Learn More on Karen K. Mcginnis' trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 19 times. They sold a total of 21,102 shares worth more than $8,202,908.23. The most recent insider tranaction occured on July, 7th when SVP Alexander Aravanis sold 539 shares worth more than $107,800.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 7/7/2022.

Karen K. Mcginnis Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2020Sell218$300.00$65,400.001,538View SEC Filing Icon  
11/6/2020Sell312$310.10$96,751.202,184View SEC Filing Icon  
8/10/2020Sell1,856$357.01$662,610.562,350View SEC Filing Icon  
See Full Table

Karen K. Mcginnis Buying and Selling Activity at Illumina

This chart shows Karen K McGinnis's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $190.79
Low: $183.65
High: $194.22

50 Day Range

MA: $206.33
Low: $184.12
High: $227.44

2 Week Range

Now: $190.79
Low: $173.45
High: $428.00


2,775,675 shs

Average Volume

1,292,445 shs

Market Capitalization

$29.97 billion

P/E Ratio


Dividend Yield